Tenax Therapeutics, Inc.

NASDAQ:TENX

Biotechnology

Healthcare
$1.91 +0.88%

+$0.10 today

Market cap
$50.66M
Beta
0.97
P/E (TTM)
-9.4
EPS (TTM)
-$1.28
52W Low $5.34High $18.38

Volume 0.70M

Average 0.62M

TENX Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Tenax Therapeutics, Inc.NASDAQ: TENX

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 45.23M shares rose 23.6% year over year, behind the +118.4% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 15.3% from the prior quarter. Over 3 fiscal years it compounded at +1187.1% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +23.6% toward the trailing-twelve-month pace of +118.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
45.23M+15.3% QoQ
Last fiscal yearDec 2025
39.22M+156.8% YoY
LTMMar 2026
40.94M+118.4% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+23.6%——
1 year+156.8%——
3-year CAGR+1187.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
39.22M USD
Year-over-year change
+156.8%
4-year CAGR
+643.1%

Weighted Avg Shares (Diluted) vs competitors

How TENX compares with its peers on the latest reported figures

  • TENX's LTM Mar 2026 weighted avg shares (diluted) of 40.94M shares is the 2nd highest of the 7 companies compared; the peer median is 26.78M shares.
  • Its year-over-year change of +118.4% is the 3rd highest of 7, against a peer median of +32.4%.
  • Over three fiscal years its annual growth of +1187.1% compares with a peer median of +35.7%.
TENX Competitors Peer median
Weighted Avg Shares (Diluted) for TENX and competitors
Company Period LTM YoY 3-year CAGR
SABSSAB Biotherapeutics, Inc.LTM Jun 202668.13M +634.4%+141.6%
TENXTenax Therapeutics, Inc.LTM Mar 202640.94M +118.4%+1187.1%
NERVMinerva Neurosciences, Inc.LTM Jun 202635.42M +368.0%+16.6%
ANTXAN2 Therapeutics, Inc.LTM Mar 202631.18M +4.3%+25.4%
BOLDBoundless Bio, Inc.LTM Mar 202622.38M +7.1%+0.2%
QTTBQ32 Bio Inc.LTM Mar 202612.78M +5.6%+56.9%
VRCAVerrica Pharmaceuticals Inc.LTM Mar 202610.07M +57.7%+46.1%
Peer median (excluding TENX) 26.78M+32.4%+35.7%

Competitors are the stored peer set for TENX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development25.15M5.38M3.23M12.71M32.67M
Selling, General & Admin7.58M5.68M5.01M6.79M23.71M
Operating Expenses32.73M11.05M8.23M19.49M56.39M
Depreciation & Amortization108.98K113.33K8K00
EBITDA(32.36M)(10.93M)(7.68M)(17.58M)(52.6M)
EBITDA Margin—————
Operating Income(32.73M)(11.05M)(8.23M)(19.49M)(56.39M)
Operating Margin—————
Interest Income0001.91M3.82M
Interest Expense9494.44K23.97K23K0
Other Income / Expenses253.88K4.75K523K1.89M3.79M
Income Before Tax(32.47M)(11.05M)(7.71M)(17.6M)(52.6M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(32.47M)(11.05M)(7.71M)(17.6M)(52.6M)
Net Margin—————
EPS (Basic)(2,524.80)(600.80)(31.09)(1.15)(1.34)
EPS (Diluted)(2,524.80)(600.80)(31.04)(1.15)(1.34)
Weighted Avg Shares12.86K18.39K248K15.27M39.22M
Weighted Avg Shares (Diluted)12.86K18.39K248.45K15.27M39.22M

Tenax Therapeutics, Inc.

NASDAQ:TENX

Intrinsic Alpha fair value

Locked

Current Price

$1.91

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.